Literature DB >> 26463508

KN-93 inhibits IKr in mammalian cardiomyocytes.

Bence Hegyi1, Ye Chen-Izu2, Zhong Jian1, Rafael Shimkunas3, Leighton T Izu1, Tamas Banyasz4.   

Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93 is widely used in multiple fields of cardiac research especially for studying the mechanisms of cardiomyopathy and cardiac arrhythmias. Whereas KN-93 is a potent inhibitor of CaMKII, several off-target effects have also been found in expression cell systems and smooth muscle cells, but there is no information on the KN93 side effects in mammalian ventricular myocytes. In this study we explore the effect of KN-93 on the rapid component of delayed rectifier potassium current (IKr) in the ventricular myocytes from rabbit and guinea pig hearts. Our data indicate that KN-93 exerts direct inhibitory effect on IKr that is not mediated via CaMKII. This off-target effect of KN93 should be taken into account when interpreting the data from using KN93 to investigate the role of CaMKII in cardiac function.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CaMKII; I(Kr); KN-93; Off target effect; Pharmacology; Ventricular myocytes

Mesh:

Substances:

Year:  2015        PMID: 26463508      PMCID: PMC4689637          DOI: 10.1016/j.yjmcc.2015.10.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

Review 1.  Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  Andy Hudmon; Howard Schulman
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations.

Authors:  Balazs Horvath; Tamas Banyasz; Zhong Jian; Bence Hegyi; Kornel Kistamas; Peter P Nanasi; Leighton T Izu; Ye Chen-Izu
Journal:  J Mol Cell Cardiol       Date:  2013-09-06       Impact factor: 5.000

3.  KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.

Authors:  Saman Rezazadeh; Thomas W Claydon; David Fedida
Journal:  J Pharmacol Exp Ther       Date:  2005-12-20       Impact factor: 4.030

4.  KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart.

Authors:  M E Anderson; A P Braun; Y Wu; T Lu; Y Wu; H Schulman; R J Sung
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

5.  Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes.

Authors:  S Tessier; P Karczewski; E G Krause; Y Pansard; C Acar; M Lang-Lazdunski; J J Mercadier; S N Hatem
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

6.  A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II.

Authors:  A Ishida; I Kameshita; S Okuno; T Kitani; H Fujisawa
Journal:  Biochem Biophys Res Commun       Date:  1995-07-26       Impact factor: 3.575

Review 7.  Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.

Authors:  Mark E Anderson
Journal:  Pharmacol Ther       Date:  2005-01-12       Impact factor: 12.310

8.  Sequential dissection of multiple ionic currents in single cardiac myocytes under action potential-clamp.

Authors:  Tamas Banyasz; Balazs Horvath; Zhong Jian; Leighton T Izu; Ye Chen-Izu
Journal:  J Mol Cell Cardiol       Date:  2011-01-06       Impact factor: 5.000

Review 9.  Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.

Authors:  Paari Dominic Swaminathan; Anil Purohit; Thomas J Hund; Mark E Anderson
Journal:  Circ Res       Date:  2012-06-08       Impact factor: 17.367

Review 10.  CaMKII inhibitors: from research tools to therapeutic agents.

Authors:  Patricia Pellicena; Howard Schulman
Journal:  Front Pharmacol       Date:  2014-02-20       Impact factor: 5.810

View more
  12 in total

1.  CaMKII blockade, cardiac conduction, and arrhythmia.

Authors:  Mark Warren; Alexey V Zaitsev
Journal:  Cardiovasc Res       Date:  2017-12-01       Impact factor: 10.787

2.  Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart.

Authors:  Mark Warren; Katie J Sciuto; Tyson G Taylor; Vivek Garg; Natalia S Torres; Junko Shibayama; Kenneth W Spitzer; Alexey V Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

Review 3.  Vascular CaMKII: heart and brain in your arteries.

Authors:  Fanny Toussaint; Chimène Charbel; Bruce G Allen; Jonathan Ledoux
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-15       Impact factor: 4.249

4.  β-adrenergic regulation of late Na+ current during cardiac action potential is mediated by both PKA and CaMKII.

Authors:  Bence Hegyi; Tamás Bányász; Leighton T Izu; Luiz Belardinelli; Donald M Bers; Ye Chen-Izu
Journal:  J Mol Cell Cardiol       Date:  2018-09-18       Impact factor: 5.000

5.  Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation.

Authors:  Fan Wang; Kati Tarkkonen; Vappu Nieminen-Pihala; Kenichi Nagano; Rana Al Majidi; Tero Puolakkainen; Petri Rummukainen; Jemina Lehto; Anne Roivainen; Fu-Ping Zhang; Outi Mäkitie; Roland Baron; Riku Kiviranta
Journal:  J Bone Miner Res       Date:  2019-03-07       Impact factor: 6.741

6.  The role of stretch, tachycardia and sodium-calcium exchanger in induction of early cardiac remodelling.

Authors:  Natasa Djalinac; Senka Ljubojevic-Holzer; Ingrid Matzer; Ewald Kolesnik; Katharina Jandl; Birgit Lohberger; Peter Rainer; Akos Heinemann; Simon Sedej; Dirk von Lewinski; Egbert Bisping
Journal:  J Cell Mol Med       Date:  2020-06-22       Impact factor: 5.310

7.  CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.

Authors:  Kathryn G Helmstadter; Senka Ljubojevic-Holzer; Brent M Wood; Khanha D Taheri; Simon Sedej; Jeffrey R Erickson; Julie Bossuyt; Donald M Bers
Journal:  Basic Res Cardiol       Date:  2021-02-15       Impact factor: 17.165

8.  Electroacupuncture Attenuates CFA-Induced Inflammatory Pain by Regulating CaMKII.

Authors:  Yixiao Gu; Shuangdong Chen; Yunchang Mo; Yingying Tu; Na Chen; Xiaoyong Zhao; Shan Li; Qimin Yu; Qinxue Dai; Junlu Wang
Journal:  Neural Plast       Date:  2020-12-31       Impact factor: 3.599

9.  Inhibition of cardiac CaMKII to cure heart failure: step by step towards translation?

Authors:  Friederike Cuello; Kristina Lorenz
Journal:  Basic Res Cardiol       Date:  2016-09-28       Impact factor: 17.165

Review 10.  Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond.

Authors:  Junxia Zhang; Dairu Liu; Mao Zhang; Yan Zhang
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.